Suggamadex and Fast-track Cardiac Anesthesia in a Developing Country

Surgery for Congenital Heart Disease Clinical Trial

Official title:

Retrospective Chart Review of Fast-track Cardiac Anesthesia Using Suggamadex for Rapid Reversal of Neuromuscular Blockade Following Cardiac Surgery in a Developing Country

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02704351
• Other study ID #: IRB15-01162
• Status: Completed
• Start date: February 2016
• Est. completion date: August 2016

Study information

• Verified date: May 2023
• Source: Nationwide Children's Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to retrospectively review our preliminary experience during a surgical trip to Tuxtla, Mexico, using suggamadex to reverse neuromuscular blockade following CPB and cardiac surgery for repair of CHD in infants and children.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 14
• Est. completion date: August 2016
• Est. primary completion date: August 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 0 Years to 18 Years

Eligibility

Inclusion Criteria:

• Patients who underwent cardiac surgery and cardiopulmonary bypass in Tuxtla, Mexico in September 2015.

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• Heart Defects, Congenital
• Heart Diseases
• Suggamadex
• Surgery for Congenital Heart Disease

Intervention

Procedure:
• Surgery
Sugammadex to reverse neuromuscular blockade

Locations

Country	Name	City	State
United States	Nationwide Children's Hospital	Columbus	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
Joseph D. Tobias

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Clinical effects of the reversal of neuromuscular blockade with suggamadex following surgery for congenital heart disease in infants and children		After cardiac surgery, on average within 5 minutes